Tuesday, April 15, 2008

Pathway Medical Raises $24.5M

Kirkland-based Pathway Medical Technologies, which develops endovascular treatments for peripheral arterial disease, said today that it has raised $24.5M in a Series C-1 round of financing. The funding came from HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital and individual investors. Pathway said the funding will go towards commercialization of its products, and specifically to build a sales and manufacturing organization. More information »